J&J's real-world bladder cancer study started in HealthVerity Marketplace
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
Understanding re-identification risk in PPRL: key takeaways from our expert webinar
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL). While PPRL remains essential for de-identified data exchange, the study presented during our recent webinar shows that certain token-based approaches...
How government agencies use HealthVerity for public health and AI-powered research
Government health agencies are increasingly turning to real-world data (RWD) for public health...
HealthVerity Notes: The hidden goldmine in healthcare data
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
Building better AI mortality models with Verified data
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
HealthVerity real-world data supports CDC study on HIV PrEP surveillance
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
The Marketplace model is winning: key insights from our webinar
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...
The GLP-1 trend: What the real-world data reveals
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Link between prostate cancer, mental health: The importance of real-world insights
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
What everyone’s missing about data quality for AI and FDA readiness
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
HealthVerity at ISPOR 2025: Solving RWD Challenges in Pharma and HEOR
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...